Search - tctmd.com

Displaying 1 - 20 of 300

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

Caitlin E. Cox

April 01, 2026

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

L.A. McKeown

March 28, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

News Daily News

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

L.A. McKeown

March 06, 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2026

Michael O'Riordan

March 02, 2026

News Daily News

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

L.A. McKeown

February 19, 2026

News Conference News EAPCI 2026

Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress

Caitlin E. Cox

February 19, 2026

News Daily News

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Caitlin E. Cox

January 08, 2026

News Opinion Editor's Corner

TCTMD’s Biggest News of 2025

Michael O'Riordan

January 01, 2026

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Conference News VIVA 2025

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

L.A. McKeown

November 07, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

Caitlin E. Cox

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News ESC 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Caitlin E. Cox

September 01, 2025

News Conference News ACC 2025

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Caitlin E. Cox

March 29, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

L.A. McKeown

December 12, 2024

Advertisement

TCTMD’s Top 10 Most Popular Stories for March 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

What’s Going to Be Hot at ACC 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Many PE Teams Embraced Mechanical Thrombectomy Early On: PERT Registry

TCTMD’s Top 10 Most Popular Stories for February 2026

AHA/ACC Guideline Tackles Evidence-Based Acute PE Care

Pulmonary Embolism: Studies Chart Gaps in Care but Also Progress

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

TCTMD’s Biggest News of 2025

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss

What’s Going to Be Hot at AHA 2025?

TCTMD’s Top 10 Most Popular Stories for October 2025

Mechanical Thrombectomy Outshines Anticoagulation Alone in STORM-PE

What’s Going to Be Hot at TCT 2025

HI-PRO: Oral Apixaban for 1 Year Protective, Safe in Provoked VTE Patients

Low-Dose Apixaban Prevents Recurrent VTE in Cancer Beyond 6 Months: API-CAT

Top Endovascular News of 2024

As More Peripheral Interventions Go Radial, the AHA Offers Some Insights

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content